The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)

OBJECTIVE: Randomized controlled trials have shown that growth hormone (GH) therapy has effects on growth, metabolism, and body composition. GH therapy is prescribed for children with growth failure and adults with GH deficiency. Carefully conducted observational study of GH treatment affords the op...

Descripción completa

Detalles Bibliográficos
Autores principales: Höybye, Charlotte, Sävendahl, Lars, Christesen, Henrik Thybo, Lee, Peter, Pedersen, Birgitte Tønnes, Schlumpf, Michael, Germak, John, Ross, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641810/
https://www.ncbi.nlm.nih.gov/pubmed/23658497
http://dx.doi.org/10.2147/CLEP.S42602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641810/
https://www.ncbi.nlm.nih.gov/pubmed/23658497
http://dx.doi.org/10.2147/CLEP.S42602

Ejemplares similares